Envafolimab Inhibits the Growth of Gastric Cancer Cells with Low PD-L1 Expression through the DDX20/NF-κB/TNF-α Signaling Pathway.

Zhuanxia Dong Zefeng Yang Jing Ren Feng Li Yusheng Wang Yuanyuan Yu

Published in: Current cancer drug targets (2024)

This study confirmed that envafolimab could inhibit the growth of gastric cancer cells with low PD-L1 expression by down-regulating DDX20 expression and regulating the NFκB/TNF-α signaling pathway.

Keyphrases

signaling pathway
pi k akt
rheumatoid arthritis
induced apoptosis
epithelial mesenchymal transition
poor prognosis
lps induced
nuclear factor
endoplasmic reticulum stress